Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: A role for ovarian hormones

Journal of Lipid Research

Volumn 53, Issue 3, 2012, Pages 379-389

  Martinez, Melissa N ^c   Emfinger, Christopher H ^a,b   Overton, Matthew ^c,g   Hill, Salisha ^c   Ramaswamy, Tara S ^c   Cappel, David A ^c   Wu, Ke ^b,f   Fazio, Sergio ^d   McDonald, W Hayes ^e   Hachey, David L ^e   Tabb, David L ^c   Stafford, John M ^a,b,c  

^a Tennessee Valley Healthcare System   (United States)

^b Division of Diabetes Endocrinology and Metabolism   (United States)

^c Department of Molecular Physiology and Biophysics ^*  (United States)

^d Atherosclerosis Research Unit   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WUHAN UNIVERSITY   (China)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cholesteryl ester transfer protein; High density lipoprotein; Hyperglycemic clamp; Menopause; Proteomics; Triglycerides

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; IMPAIRED GLUCOSE TOLERANCE; LIPID COMPOSITION; LIPID DIET; LIPID METABOLISM; LOW FAT DIET; MOUSE; NONHUMAN; OBESITY; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SHAM PROCEDURE; TRANSGENIC MOUSE; WEIGHT GAIN;

ANIMALS; APOLIPOPROTEIN C-II; APOLIPOPROTEINS A; BLOTTING, WESTERN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPUTATIONAL BIOLOGY; DIET, HIGH-FAT; FEMALE; HYPERINSULINISM; INSULIN; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; MICE; MICE, TRANSGENIC; OBESITY; OVARIECTOMY; TRIGLYCERIDES; WEIGHT GAIN;

EID: 84857772650     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M019752     Document Type: Article

References (47)

1. Lamarche, B., K. D. Uffelman, A. Carpentier, J. S. Cohn, G. Steiner, P. H. Barrett, and G. F. Lewis. 1999. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J. Clin. Invest. 103: 1191-1199. (Pubitemid 29207253)
2. Lewis, G. F., K. D. Uffelman, L. W. Szeto, B. Weller, and G. Steiner. 1995. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J. Clin. Invest. 95: 158-166.
3. Horowitz, B. S., I. J. Goldberg, J. Merab, T. M. Vanni, R. Ramakrishnan, and H. N. Ginsberg. 1993. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J. Clin. Invest. 91: 1743-1752. (Pubitemid 23127380)
4. Van Lenten, B. J., S. Y. Hama, F. C. de Beer, D. M. Stafforini, T. M. McIntyre, S. M. Prescott, B. N. La Du, A. M. Fogelman, and M. Navab. 1995. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invest. 96: 2758-2767.
5. Eckel, R. H., W. W. Barouch, and A. G. Ershow. 2002. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease. Circulation. 105: 2923-2928. (Pubitemid 34666109)
6. Goldberg, I. J., R. H. Eckel, and R. McPherson. 2011. Triglycerides and heart disease: still a hypothesis? Arterioscler. Thromb. Vasc. Biol. 31: 1716-1725.
7. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1989. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J. Clin. Invest. 84: 262-269. (Pubitemid 19170118)
8. Collins, L. A., and M. Olivier. 2010. Quantitative comparison of lipoprotein fractions derived from human plasma and serum by liquid chromatography-tandem mass spectrometry. Proteome Sci. 8: 42.
9. Julve, J., J. C. Escola-Gil, N. Rotllan, C. Fievet, E. Vallez, C. de la Torre, V. Ribas, J. H. Sloan, and F. Blanco-Vaca. 2010. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome. Arterioscler. Thromb. Vasc. Biol. 30: 232-238.
10. Davidsson, P., J. Hulthe, B. Fagerberg, and G. Camejo. 2010. Proteomics of apolipoproteins and associated proteins from plasma high-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 30: 156-163.
11. Stahlman, M., P. Davidsson, I. Kanmert, B. Rosengren, J. Boren, B. Fagerberg, and G. Camejo. 2008. Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr. J. Lipid Res. 49: 481-490. (Pubitemid 351213633)
12. Vaisar, T., S. Pennathur, P. S. Green, S. A. Gharib, A. N. Hoofnagle, M. C. Cheung, J. Byun, S. Vuletic, S. Kassim, P. Singh, et al. 2007. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 117: 746-756. (Pubitemid 46348533)
13. Navab, M., S. Y. Hama, G. P. Hough, G. Subbanagounder, S. T. Reddy, and A. M. Fogelman. 2001. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J. Lipid Res. 42: 1308-1317. (Pubitemid 32744255)
14. Lewis, G. F., and D. J. Rader. 2005. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96: 1221-1232. (Pubitemid 40962099)
15. Fazio, S., and M. F. Linton. 2010. High-density lipoprotein therapeutics and cardiovascular prevention. J. Clin. Lipidol. 4: 411-419.
16. Khera, A. V., M. Cuchel, M. de la Llera-Moya, A. Rodrigues, M. F. Burke, K. Jafri, B. C. French, J. A. Phillips, M. L. Mucksavage, R. L. Wilensky, et al. 2011. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N. Engl. J. Med. 364: 127-135.
17. Feingold, K. R., and C. Grunfeld. 2010. The acute phase response inhibits reverse cholesterol transport. J. Lipid Res. 51: 682-684.
18. Mittendorfer, B., B. W. Patterson, S. Klein, and L. S. Sidossis. 2003. VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity. Am. J. Physiol. Endocrinol. Metab. 284: E708-E715. (Pubitemid 36323863)
19. Magkos, F., E. Fabbrini, B. S. Mohammed, B. W. Patterson, S. Klein, and B. Mittendorfer. 2010. Estrogen deficiency after menopause does not result in male very-low-density lipoprotein metabolism phenotype. J. Clin. Endocrinol. Metab. 95: 3377-3384.
20. Horton, T. J., E. C. Gayles, P. A. Prach, T. A. Koppenhafer, and M. J. Pagliassotti. 1997. Female rats do not develop sucrose-induced insulin resistance. Am. J. Physiol. 272: R1571-R1576.
21. Masucci-Magoulas, L., A. Plump, X. C. Jiang, A. Walsh, J. L. Breslow, and A. R. Tall. 1996. Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice: a novel mechanism signals changes in plasma cholesterol levels. J. Clin. Invest. 97: 154-161.
22. Marotti, K. R., C. K. Castle, T. P. Boyle, A. H. Lin, R. W. Murray, and G. W. Melchior. 1993. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature. 364: 73-75. (Pubitemid 23233459)
23. Jiang, X. C., L. B. Agellon, A. Walsh, J. L. Breslow, and A. Tall. 1992. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice: dependence on natural flanking sequences. J. Clin. Invest. 90: 1290-1295.
24. Berti, J. A., A. C. Casquero, P. R. Patricio, E. J. B. Bighetti, E. M. Carneiro, A. C. Boschero, and H. C. F. Oliveira. 2003. Cholesteryl ester transfer protein expression is down-regulated in hyperinsulinemic transgenic mice. J. Lipid Res. 44: 1870-1876. (Pubitemid 37356659)
25. Arai, T., S. Yamashita, K. Hirano, N. Sakai, K. Kotani, S. Fujioka, S. Nozaki, Y. Keno, M. Yamane, E. Shinohara, et al. 1994. Increased plasma cholesteryl ester transfer protein in obese subjects: a possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler. Thromb. 14: 1129-1136.
26. Magkos, F., B. S. Mohammed, and B. Mittendorfer. 2009. Plasma lipid transfer enzymes in non-diabetic lean and obese men and women. Lipids. 44: 459-464.
27. Marotti, K. R., C. K. Castle, R. W. Murray, E. F. Rehberg, H. G. Polites, and G. W. Melchior. 1992. The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism: insights from studies with transgenic mice. Arterioscler. Thromb. 12: 736-744.
28. Ayala, J. E., V. T. Samuel, G. J. Morton, S. Obici, C. M. Croniger, G. I. Shulman, D. H. Wasserman, and O. P. McGuinness. 2010. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis. Model Mech. 3: 525-534.
29. Ayala, J. E., D. P. Bracy, O. Mcguinness, and D. H. Wasserman. 2006. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes. 55: 390-397. (Pubitemid 43343268)
30. Hasty, A. H., H. Shimano, J. Osuga, I. Namatame, A. Takahashi, N. Yahagi, S. Perrey, Y. Iizuka, Y. Tamura, M. Amemiya-Kudo, et al. 2001. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J. Biol. Chem. 276: 37402-37408.
31. Washburn, M. P., D. Wolters, and J. R. Yates 3rd. 2001. Large-scale analysis of the yeast proteome by multidimensional protein identifi cation technology. Nat. Biotechnol. 19: 242-247. (Pubitemid 32220565)
32. MacCoss, M. J., W. H. McDonald, A. Saraf, R. Sadygov, J. M. Clark, J. J. Tasto, K. L. Gould, D. Wolters, M. Washburn, A. Weiss, et al. 2002. Shotgun identification of protein modifications from protein complexes and lens tissue. Proc. Natl. Acad. Sci. USA. 99: 7900-7905. (Pubitemid 34650977)
33. Link, A. J., J. Eng, D. M. Schieltz, E. Carmack, G. J. Mize, D. R. Morris, B. M. Garvik, and J. R. Yates 3rd. 1999. Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 17: 676-682. (Pubitemid 29316146)
34. Kessner, D., M. Chambers, R. Burke, D. Agus, and P. Mallick. 2008. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics. 24: 2534-2536.
35. Tabb, D. L., C. G. Fernando, and M. C. Chambers. 2007. MyriMatch: highly accurate tandem mass spectral peptide identification by multivariate hypergeometric analysis. J. Proteome Res. 6: 654-661. (Pubitemid 46340169)
36. Zhang, B., M. C. Chambers, and D. L. Tabb. 2007. Proteomic parsimony through bipartite graph analysis improves accuracy and transparency. J. Proteome Res. 6: 3549-3557. (Pubitemid 47522746)
37. Ma, Z. Q., S. Dasari, M. C. Chambers, M. D. Litton, S. M. Sobecki, L. J. Zimmerman, P. J. Halvey, B. Schilling, P. M. Drake, B. W. Gibson, et al. 2009. IDPicker 2.0: improved protein assembly with high discrimination peptide identification filtering. J. Proteome Res. 8: 3872-3881.
38. Li, M., W. Gray, H. Zhang, C. H. Chung, D. Billheimer, W. G. Yarbrough, D. C. Liebler, Y. Shyr, and R. J. Slebos. 2010. Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling. J. Proteome Res. 9: 4295-4305.
39. Wu, K., D. Cappel, M. Martinez, and J. M. Stafford. 2010. Impaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoprotein. Endocrinology. 151: 3566-3576.
40. Sadur, C. N., and R. H. Eckel. 1982. Insulin stimulation of adipose tissue lipoprotein lipase: use of the euglycemic clamp technique. J. Clin. Invest. 69: 1119-1125. (Pubitemid 12115676)
41. Dasari, S., M. C. Chambers, R. J. Slebos, L. J. Zimmerman, A. J. Ham, and D. L. Tabb. 2010. TagRecon: high-throughput mutation identification through sequence tagging. J. Proteome Res. 9: 1716-1726.
42. Dasari, S., M. C. Chambers, S. G. Codreanu, D. C. Liebler, B. C. Collins, S. R. Pennington, W. M. Gallagher, and D. L. Tabb. 2011. Sequence tagging reveals unexpected modifications in toxicoproteomics. Chem. Res. Toxicol. 24:204-216.
43. Matthews, K. A., E. Meilahn, L. H. Kuller, S. F. Kelsey, A. W. Caggiula, and R. R. Wing. 1989. Menopause and risk factors for coronary heart disease. N. Engl. J. Med. 321: 641-646. (Pubitemid 19221308)
44. Mozaffarian, D., E. B. Rimm, and D. M. Herrington. 2004. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am. J. Clin. Nutr. 80: 1175-1184. (Pubitemid 41350676)
45. Rossouw, J. E., R. L. Prentice, J. E. Manson, L. Wu, D. Barad, V. M. Barnabei, M. Ko, A. Z. LaCroix, K. L. Margolis, and M. L. Stefanick. 2007. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 297: 1465-1477. (Pubitemid 46556472)
46. Woodard, G. A., M. M. Brooks, E. Barinas-Mitchell, R. H. Mackey, K. A. Matthews, and K. Sutton-Tyrrell. 2011. Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women. Menopause. 18: 376-384.
47. Mittendorfer, B., B. W. Patterson, and S. Klein. 2003. Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am. J. Clin. Nutr. 77: 573-579. (Pubitemid 36258564)